A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
Clinical trial NCT04075604 · COMPLETED
Trial details
- NCT number
- NCT04075604
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2021-07-27
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.